dihydrofolate reductase inhibitors (Dana-Farber)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedihydrofolate reductase inhibitors (Dana-Farber)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsToxoplasmosis +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer Institute
Active IndicationsN/A
Inactive IndicationsToxoplasmosis +[2] 

Other Information

ATC CodeN/A
Related LinksN/A